电子邮件 | ksr***@***.com | 获取Email |
---|
电子邮件 | ksr***@***.com | 获取Email |
---|
Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies. Wugen is based out of St. Louis, Missouri and San Diego, California.
公司 | Wugen |
---|---|
职位 | Chief Executive Officer |
地点 | United States |
http://www.linkedin.com/in/kusrinivasan | |
部门 | c_suite |
头衔 | President & CEO, Wugen |
Wugen Chief Executive Officer
2023-03-01 -
Transcenta Member Board of Directors
2022-12-01 -
Aurigene Discovery Technologies Member Board of Directors
2022-09-01 -
Turning Point Therapeutics Executive Vice President & CBO
2021-06-01 - 2022-08-01
Turning Point Therapeutics Executive Vice President & CBO
2021-06-01 - 2022-08-01
Kumar Srinivasan 在 Wugen 担任 President & CEO, Wugen
Kumar Srinivasan 在 Wugen 的职位是 President & CEO, Wugen
Kumar Srinivasan 的电子邮件地址是 ksr***@***.com
Kumar Srinivasan 的电话号码是 -
Kumar Srinivasan 的公司电话号码是 +163****
Kumar Srinivasan 在 research 工作。
Kumar Srinivasan 的一些同事包括Preeta Dasgupta、Sarah Perdue、John Gierer、Courtney EavesKumar Srinivasan、。
Kumar Srinivasan联系方式: 电子邮件地址:ksr***@***.com 电话号码:-
Kumar Srinivasan 的个人领英是:http://www.linkedin.com/in/kusrinivasan
Kumar Srinivasan 的办公地点:4340 duncan avenue, st. louis, mo, united states
Top-ranked on G2 Crowd
全球B2B企业库 海关贸易数据 展会采购数据
全球B2B企业库
海关贸易数据
展销采购数据
Top-ranked on G2 Crowd